BioCatalyst

BT8009, Pembrolizumab — catalyst calendar

1 verified catalyst event(s) referencing BT8009, Pembrolizumab, each linked to its official source. Verified as of 2026-10-21.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01 (month)
in 2mo
ESTIMATED
 READOUT
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Phase 1/2 · Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms
 BicycleTx Limited BT8009, Pembrolizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-10-21
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.